These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 8311158)

  • 1. [The realization of the antiestrogen effect of tamoxifen in endometrial adenomatosis in women of reproductive age].
    Putyrskaia NP; Chernukha GE
    Akush Ginekol (Mosk); 1993; (6):43-6. PubMed ID: 8311158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment of the endometrial adenomatosis with tamoxifen in patients of reproductive age].
    Smetnik VP; Chernukha GE; Kushlinskiĭ NE
    Biull Eksp Biol Med; 1998 Jan; 125(1):93-7. PubMed ID: 9532378
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of tamoxifen on steroid hormone receptors and hormone concentration and the results of DNA analysis by flow cytometry in endometrial carcinoma.
    Nola M; Jukić S; Ilić-Forko J; Babić D; Uzarević B; Petrovecki M; Suchanek E; Skrablin S; Dotlić S; Marusić M
    Gynecol Oncol; 1999 Mar; 72(3):331-6. PubMed ID: 10053103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of hormone therapy on the endometrium.
    Deligdisch L
    Mod Pathol; 1993 Jan; 6(1):94-106. PubMed ID: 8426860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estrogen receptor expression in an endometrial stromal sarcoma after tamoxifen therapy.
    Liao JB; Lin JY
    Eur J Gynaecol Oncol; 2001; 22(6):417-9. PubMed ID: 11874071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The pathogenetic basis for using antiestrogens in treating patients with hyperplastic processes of the endometrium in the postmenopause].
    Vysotskiĭ MM; Krasnova IA; Kostyleva OI; Eremin VL
    Akush Ginekol (Mosk); 1993; (6):46-9. PubMed ID: 8311159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of endometrial proliferation in pipelle biopsies in tamoxifen-treated postmenopausal women with breast cancer in Kuwait.
    Al-Azemi M; Labib NS; Motawy MM; Temmim L; Moussa MA; Omu AE
    Med Princ Pract; 2004; 13(1):30-4. PubMed ID: 14657616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of a new clinically relevant antiestrogen (GW5638) related to tamoxifen on breast and endometrial cancer growth in vivo.
    Dardes RC; O'Regan RM; Gajdos C; Robinson SP; Bentrem D; De Los Reyes A; Jordan VC
    Clin Cancer Res; 2002 Jun; 8(6):1995-2001. PubMed ID: 12060645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The effect of danazol and tamoxifen on endometrial hyperplasia].
    Soh E
    Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-3):1612-22. PubMed ID: 2730056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of replication-licensing factors MCM2 and MCM3 in normal, hyperplastic, and carcinomatous endometrium: correlation with expression of Ki-67 and estrogen and progesterone receptors.
    Kato K; Toki T; Shimizu M; Shiozawa T; Fujii S; Nikaido T; Konishi I
    Int J Gynecol Pathol; 2003 Oct; 22(4):334-40. PubMed ID: 14501812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogen and progesterone receptors in the endometrium of postmenopausal breast cancer patients treated with tamoxifen and progestogens.
    Cohen I; Altaras MM; Beyth Y; Shapira J; Figer A; Tepper R; Cordoba M; Yigal D; Bernheim J
    Gynecol Oncol; 1997 Apr; 65(1):83-8. PubMed ID: 9103396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical estrogen receptor assessment in hyperplastic, neoplastic, and physiologic endometria.
    Huang SJ; Cheng L; Lewin KJ; Fu YS
    Pathol Res Pract; 1991 May; 187(4):487-95. PubMed ID: 1876529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maturation of vaginal and endometrial epithelium in postmenopausal breast cancer patients receiving long-term tamoxifen.
    Lahti E; Vuopala S; Kauppila A; Blanco G; Ruokonen A; Laatikainen T
    Gynecol Oncol; 1994 Dec; 55(3 Pt 1):410-4. PubMed ID: 7835781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estrogen and progesterone receptor expression in postmenopausal tamoxifen-exposed endometrial pathologies.
    Cohen I; Beyth Y; Altaras MM; Shapira J; Tepper R; Cardoba M; Yigael D; Figer A; Fishman A; Berenhein J
    Gynecol Oncol; 1997 Oct; 67(1):8-15. PubMed ID: 9345349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tamoxifen and endometrial cancer.
    Segna RA; Dottino PR; Deligdisch L; Cohen CJ
    Mt Sinai J Med; 1992 Oct; 59(5):416-8. PubMed ID: 1435840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Precancerous lesion of the endometrium and endometrial morphology in patients with tamoxifen therapy].
    Schmidt D; Horn LC
    Zentralbl Gynakol; 2002 Jan; 124(1):3-9. PubMed ID: 11873307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Risk of endometrial hyperplasia and carcinoma in breast cancer patients receiving adjuvant tamoxifen].
    Semiglazov VF; Maksimov SIa; Bulgatova EA; Meshkova IE; Chepik OF; Berstein LM
    Vopr Onkol; 2003; 49(2):198-204. PubMed ID: 12785205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Malignant transformation of the human endometrium is associated with overexpression of lactoferrin messenger RNA and protein.
    Walmer DK; Padin CJ; Wrona MA; Healy BE; Bentley RC; Tsao MS; Kohler MF; McLachlan JA; Gray KD
    Cancer Res; 1995 Mar; 55(5):1168-75. PubMed ID: 7867003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Role of steroid hormones and related biological substances in the etiology of endometrial carcinomas].
    Lang-Avérous G; Rupp K; Wehner H; Dallenbach-Hellweg G
    Verh Dtsch Ges Pathol; 1991; 75():366-9. PubMed ID: 1724843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Morphologic endometrium changes with tamoxifen].
    Dallenbach-Hellweg G; Hahn U; Schmidt D
    Zentralbl Gynakol; 1996; 118(6):365-9. PubMed ID: 8768015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.